AMN Healthcare AMN Healthcare Services (AMN) Financials
$34.26
As on 18-Sep-2026 16:10EDT
Market cap
$1,338 Mln
Revenue (TTM)
$3,434 Mln
P/E Ratio
12.8
P/B Ratio
1.8
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
3,434.32
|
2,730.43
|
2,983.78
|
3,789.25
|
5,243.24
|
3,984.24
|
|||||
|
Cost of Revenue
|
2,480.06
|
1,956.37
|
2,064.41
|
2,539.67
|
3,526.56
|
2,674.63
|
|||||
|
Gross Profit
|
954.26
|
774.06
|
919.38
|
1,249.58
|
1,716.68
|
1,309.60
|
|||||
|
Operating Expenses
|
793.58
|
740.89
|
1,022.05
|
911.15
|
1,069.58
|
831.60
|
|||||
|
Operating Profit (EBIT)
|
160.68
|
33.17
|
-102.67
|
338.43
|
647.10
|
478.00
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
164.19
|
-101.06
|
-172.57
|
284.29
|
606.70
|
443.92
|
|||||
|
Provision for Tax
|
59.27
|
-5.36
|
-25.60
|
73.61
|
162.65
|
116.53
|
|||||
|
Profit after Tax (Net Income)
|
104.92
|
-95.70
|
-146.98
|
210.68
|
444.05
|
327.39
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
21.59
|
-95.70
|
-146.98
|
210.68
|
444.05
|
327.39
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
741.28
|
642.11
|
706.62
|
831.26
|
1,043.63
|
1,162.03
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
852.21
|
874.39
|
1,163.32
|
1,437.02
|
986.78
|
1,000.49
|
|||||
|
Current Liabilities
|
770.49
|
577.61
|
545.79
|
656.12
|
857.93
|
969.39
|
|||||
|
Total Liabilities
|
3,134.47
|
2,094.11
|
2,415.73
|
2,924.39
|
2,888.35
|
3,131.91
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,494.72
|
1,548.73
|
1,820.81
|
2,082.71
|
1,794.71
|
1,782.84
|
|||||
|
Current Assets
|
869.26
|
545.38
|
594.92
|
841.69
|
1,093.65
|
1,349.07
|
|||||
|
Total Assets
|
3,134.47
|
2,094.11
|
2,415.73
|
2,924.39
|
2,888.35
|
3,131.91
|
|||||
|
Total Debt*
|
775.81
|
803.20
|
1,097.80
|
1,350.28
|
860.96
|
867.07
|
|||||
|
Net Current Assets
|
98.77
|
-32.24
|
49.13
|
185.56
|
235.71
|
379.68
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
269.46
|
320.42
|
372.17
|
653.73
|
305.36
|
|||||
|
Cash Flow from Investing Activities
|
--
|
4.30
|
-79.94
|
-412.49
|
-170.71
|
-107.40
|
|||||
|
Cash from Financing Activities
|
--
|
-295.89
|
-259.45
|
10.73
|
-591.87
|
-34.90
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
-108.84
|
163.06
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
2.68
|
-2.47
|
-3.84
|
5.52
|
10.22
|
6.81
|
|||||
|
Cash EPS ($)
|
2.69
|
1.57
|
0.70
|
9.74
|
13.27
|
8.91
|
|||||
|
Adjusted Book Value ($)
|
19.15
|
16.58
|
18.47
|
21.78
|
24.01
|
24.16
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
6.96
|
8.37
|
9.75
|
15.04
|
6.35
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
6.04
|
6.26
|
7.03
|
13.18
|
5.23
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-5.89
|
-7.37
|
10.31
|
22.58
|
17.21
|
|||||
|
ROE (%)
|
15.17
|
-14.19
|
-19.11
|
22.47
|
40.26
|
33.04
|
|||||
|
ROA (%)
|
3.54
|
-4.24
|
-5.50
|
7.25
|
14.75
|
11.94
|
|||||
|
EBIT Margin (%)
|
5.82
|
-2.03
|
-3.44
|
8.93
|
12.34
|
12.00
|
|||||
|
Net Margin (%)
|
3.05
|
-3.51
|
-4.93
|
5.56
|
8.47
|
8.22
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
23.99
|
-0.08
|
-0.21
|
-0.28
|
0.32
|
0.66
|
|||||
|
EBIT Growth (%)
|
168.55
|
45.97
|
-130.34
|
-47.70
|
35.38
|
220.23
|
|||||
|
Net Profit Growth (%)
|
135.23
|
34.89
|
-169.76
|
-52.56
|
35.63
|
363.30
|
|||||
|
EPS Growth (%)
|
134.48
|
0.36
|
-1.70
|
-0.46
|
0.50
|
3.60
|
|||||
|
Book Value Growth (%)
|
17.95
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
12.84
|
-6.38
|
-6.23
|
13.57
|
10.07
|
17.97
|
|||||
|
Price / Book Value
|
1.81
|
0.95
|
1.30
|
3.44
|
4.28
|
5.06
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
5.06
|
13.64
|
28.16
|
8.22
|
6.64
|
11.18
|
|||||
|
Close Price ($)
|
32.37
|
15.76
|
23.92
|
74.88
|
102.82
|
122.33
|
|||||
|
High Price ($)
|
33.48
|
30.49
|
80.18
|
113.85
|
129.04
|
129.12
|
|||||
|
Low Price ($)
|
14.87
|
14.87
|
22.47
|
57.80
|
82.76
|
67.40
|
|||||
|
Market Cap ($ Cr)
|
1,338.12
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
1.00
|
1.25
|
1.55
|
1.62
|
0.82
|
0.75
|
|||||
|
Short term debt to equity ratio
|
0.01
|
0.01
|
0.01
|
0.01
|
0.01
|
0.01
|
|||||
|
Current Ratio
|
1.13
|
0.94
|
1.09
|
1.28
|
1.27
|
1.39
|
|||||
|
Quick Ratio
|
1.13
|
--
|
--
|
1.28
|
--
|
1.29
|
|||||
|
Interest Coverage
|
5.61
|
-1.22
|
-1.47
|
6.25
|
16.02
|
14.03
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.14
|
16.08
|
17.43
|
19.70
|
18.18
|
25.82
|
|||||
|
Asset Turnover
|
1.16
|
1.21
|
1.12
|
1.30
|
1.74
|
1.45
|
|||||
|
Receivable days
|
--
|
64.15
|
77.52
|
81.92
|
69.04
|
67.79
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
10.54
|
9.60
|
|||||
|
Payable days
|
--
|
17.35
|
24.60
|
39.58
|
36.89
|
30.48
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
52.92
|
42.34
|
42.68
|
46.90
|